Successful Treatment with Secukinumab in an Erythrodermic Psoriasis Patient with End-Stage Kidney Disease on Hemodialysis: A Case Report. [PDF]
Zhang S +8 more
europepmc +1 more source
Safety profile and efficacy of secukinumab in the treatment of autoimmune myasthenia gravis: a single-center retrospective study. [PDF]
Zhang S, Song X, Wang AR, Zhang Z.
europepmc +1 more source
Combination secukinumab and surgical intervention for moderate-to-severe hidradenitis suppurativa: A retrospective cohort study. [PDF]
Xu Q +10 more
europepmc +1 more source
Neurofunctional Reversibility in Psoriasis Vulgaris After IL-17A Inhibition: A Resting-State fMRI and Neurocognitive Analysis. [PDF]
Liu J +8 more
europepmc +1 more source
Etanercept-induced sarcoidosis presenting with bilateral panuveitis: diagnostic value of ocular signs and therapeutic response to IL-17A inhibition-a case-based review. [PDF]
Bonifazi T, Cerquaglia A, Iaccheri B.
europepmc +1 more source
Successful Treatment of Post-SARS-CoV-2 Infection Reactive Arthritis With Secukinumab: A Case Report and Literature Review. [PDF]
Zhao Q +11 more
europepmc +1 more source
Long-Term Efficacy and Safety of Secukinumab in Children and Adolescents with Moderate-to-Severe Chronic Plaque Psoriasis: Four-Year Results of a Randomized, Phase III, Open-Label Trial. [PDF]
Kingo K +12 more
europepmc +1 more source
Secukinumab effectively manages ankylosing spondylitis in a hemodialysis patient without side effects. [PDF]
Zhao Z +20 more
europepmc +1 more source

